首页
探索
nav.journalClub
趋势
更多
synapse
⌘+K
语言
简体中文
简体中文
March 3, 2026
Open Access
Changes in quality of life in patients with atrial fibrillation and central sleep apnea treated with transvenous phrenic nerve stimulation
SJ
Shahrokh Javaheri
SM
Scott W. McKane
RG
Robin E. Germany
Key Points
Quality of life improvements are observed in patients with both atrial fibrillation and central sleep apnea.
Atrial fibrillation and central sleep apnea are effectively treated using transvenous phrenic nerve stimulation.
Clinical data shows significant changes in quality of life metrics among treated individuals.
The findings support the need for further exploration into combined therapies for these conditions.
Abstract
ClinicalTrials.gov identifier NCT01816776.
Read Full Paper
externally
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Changes in quality of life in patients with atrial fibrillation and central sleep apnea treated with transvenous phrenic nerve stimulation | Synapse
Cite This Study
Copy
Javaheri et al. (Tue,) studied this question.
synapsesocial.com/papers/69a7664ebadf0bb9e87dc828
https://doi.org/https://doi.org/10.1016/j.sleep.2026.108824